Website
www.bellushealth.com
Email
info@bellushealth.com
LinkedIn
Visit our page
Line of business
Therapeutics - Chronic Cough
Bellus Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders